AIDS Healthcare Foundation (AHF), the US? largest HIV/AIDS healthcare, prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, chastised US drug giant, Abbott Laboratories for its ?quid pro quo? offer earlier today to the Government of Thailand to lower its price for Abbott?s key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$1000 per patient per year?an offer contingent upon Abbott?s demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.